tiprankstipranks
Trending News
More News >
Zotefoams PLC (GB:ZTF)
LSE:ZTF
Advertisement

Zotefoams (ZTF) AI Stock Analysis

Compare
19 Followers

Top Page

GB:ZTF

Zotefoams

(LSE:ZTF)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
476.00p
▲(3.93% Upside)
Zotefoams' stock score is driven by strong technical momentum and solid cash flow performance. However, high valuation metrics and profitability challenges weigh down the score. The absence of earnings call insights and corporate events means these factors do not influence the score.

Zotefoams (ZTF) vs. iShares MSCI United Kingdom ETF (EWC)

Zotefoams Business Overview & Revenue Model

Company DescriptionZotefoams (ZTF) is a leading manufacturer of innovative, high-performance foam products, primarily serving the aerospace, automotive, medical, and industrial sectors. The company specializes in producing cross-linked polyethylene (PEX) and other advanced materials using its proprietary manufacturing processes, which allow for lightweight and durable solutions. Zotefoams is committed to sustainability and innovation, developing products that meet the stringent demands of various applications while minimizing environmental impact.
How the Company Makes MoneyZotefoams generates revenue through the sale of its foam products across multiple sectors, including aerospace, automotive, and medical. The company operates a diversified revenue model that includes direct sales to manufacturers, distributors, and end-users. Key revenue streams come from custom foam solutions tailored to specific customer needs, as well as standard product lines. Zotefoams has established significant partnerships with major companies in its target industries, enhancing its market presence and enabling access to new customer bases. Additionally, the company's focus on research and development fosters innovation, allowing it to introduce new products that capture market demand and drive sales growth.

Zotefoams Financial Statement Overview

Summary
Zotefoams shows strong revenue growth and a robust balance sheet, but faces profitability challenges with a net loss and declining EBIT margins. Cash flow performance is strong, indicating good operational cash generation and improved free cash flow.
Income Statement
55
Neutral
The recent annual report shows a decline in profitability with a negative net income, resulting in a negative net profit margin. However, the company has demonstrated revenue growth of 16.39% from the previous year, indicating a positive trajectory in sales. Gross profit margin is stable, but EBIT and EBITDA margins have decreased, reflecting pressure on operational efficiency.
Balance Sheet
65
Positive
The balance sheet remains strong with a healthy equity ratio of 62.56%, indicating a solid capital structure. However, the debt-to-equity ratio has increased slightly to 0.40, suggesting a rise in leverage. Return on equity has turned negative due to the net loss, which is a concern for profitability.
Cash Flow
70
Positive
Cash flow from operations has significantly improved, supporting a positive free cash flow. The free cash flow to net income ratio is unfavorable due to the negative net income, but the operating cash flow to net income ratio indicates operational cash generation capability. The free cash flow growth rate is strong, reflecting improved cash management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue154.16M147.79M126.97M127.37M100.75M82.65M
Gross Profit49.33M46.13M41.05M38.73M26.57M27.78M
EBITDA13.95M12.28M23.41M22.16M15.67M15.72M
Net Income712.00K-2.75M9.24M10.01M4.38M7.16M
Balance Sheet
Total Assets178.73M174.75M175.61M170.36M159.38M158.22M
Cash, Cash Equivalents and Short-Term Investments8.26M10.53M6.29M10.59M8.05M8.50M
Total Debt37.32M43.56M37.86M38.41M42.40M44.10M
Total Liabilities60.74M65.39M59.85M60.82M61.60M63.85M
Stockholders Equity117.99M109.36M115.76M109.54M97.78M94.38M
Cash Flow
Free Cash Flow19.70M11.35M-702.00K14.03M3.83M-1.85M
Operating Cash Flow32.39M25.00M7.78M21.12M10.90M10.86M
Investing Cash Flow-13.30M-13.34M-8.29M-7.09M-6.98M-13.29M
Financing Cash Flow-18.70M-7.41M-3.73M-11.53M-4.34M3.72M

Zotefoams Technical Analysis

Technical Analysis Sentiment
Positive
Last Price458.00
Price Trends
50DMA
412.03
Positive
100DMA
372.02
Positive
200DMA
323.59
Positive
Market Momentum
MACD
15.12
Negative
RSI
58.69
Neutral
STOCH
63.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ZTF, the sentiment is Positive. The current price of 458 is above the 20-day moving average (MA) of 428.30, above the 50-day MA of 412.03, and above the 200-day MA of 323.59, indicating a bullish trend. The MACD of 15.12 indicates Negative momentum. The RSI at 58.69 is Neutral, neither overbought nor oversold. The STOCH value of 63.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ZTF.

Zotefoams Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
£3.53B9.9315.96%3.66%-9.10%239.75%
£562.74M18.956.65%9.21%4.75%-3.29%
$10.43B7.12-0.05%2.87%2.86%-36.73%
£219.54M312.500.60%1.66%15.56%-92.94%
£273.08M29.543.48%2.41%-4.71%86.21%
£944.86M-16.673.37%1.36%-11.78%-92.61%
£87.83M-1.05-7.26%-4.41%2.29%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:ZTF
Zotefoams
450.00
121.04
36.79%
GB:ELM
Elementis
164.80
37.51
29.47%
GB:ESNT
Essentra
95.70
-50.93
-34.73%
GB:JMAT
Johnson Matthey
2,104.00
662.96
46.01%
GB:SYNT
Synthomer
52.30
-132.70
-71.73%
GB:VCT
Victrex
636.00
-175.39
-21.62%

Zotefoams Corporate Events

Business Operations and StrategyExecutive/Board Changes
Zotefoams Strengthens Board with New Non-Executive Director Appointment
Positive
Oct 24, 2025

Zotefoams has announced the appointment of Jack Clarke as an independent Non-Executive Director, effective from October 28, 2025. Clarke, who brings extensive experience from his previous roles as CFO at Essentra plc and Marshalls plc, will also chair the Audit Committee following Doug Robertson’s retirement at the end of the year. This strategic leadership change aims to bolster Zotefoams’ board with Clarke’s international strategy and finance expertise, aligning with the company’s sustainable growth objectives.

The most recent analyst rating on (GB:ZTF) stock is a Hold with a £476.00 price target. To see the full list of analyst forecasts on Zotefoams stock, see the GB:ZTF Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Zotefoams Directors Acquire Shares Under Incentive Plan
Positive
Oct 14, 2025

Zotefoams plc announced that directors and key managerial personnel have acquired ordinary shares under the company’s Share Incentive Plan. This transaction, compliant with UK Market Abuse Regulation, reflects the company’s commitment to aligning management interests with shareholder value, potentially reinforcing stakeholder confidence.

The most recent analyst rating on (GB:ZTF) stock is a Buy with a £5.40 price target. To see the full list of analyst forecasts on Zotefoams stock, see the GB:ZTF Stock Forecast page.

DividendsRegulatory Filings and Compliance
Zotefoams Directors Acquire Shares Under Incentive Plan
Positive
Oct 9, 2025

Zotefoams plc announced that directors and persons discharging managerial responsibilities have acquired ordinary shares under the company’s Share Incentive Plan through a dividend reinvestment program. This transaction, compliant with the UK Market Abuse Regulation, reflects ongoing engagement and investment by the company’s leadership, potentially reinforcing stakeholder confidence and aligning management interests with shareholder value.

The most recent analyst rating on (GB:ZTF) stock is a Buy with a £5.40 price target. To see the full list of analyst forecasts on Zotefoams stock, see the GB:ZTF Stock Forecast page.

Business Operations and StrategyDividends
Zotefoams Directors Acquire Shares Under Incentive Plan
Positive
Oct 9, 2025

Zotefoams plc announced that directors and persons with managerial responsibilities have acquired shares through the company’s Share Incentive Plan dividend reinvestment program. This transaction reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially enhancing stakeholder confidence and reinforcing its market position.

The most recent analyst rating on (GB:ZTF) stock is a Buy with a £5.40 price target. To see the full list of analyst forecasts on Zotefoams stock, see the GB:ZTF Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Zotefoams CFO Acquires Shares Under LTIP
Neutral
Sep 30, 2025

Zotefoams plc announced that its Group CFO, Mr. G C McGrath, acquired 20,154 ordinary shares through the vesting of a nil-cost award under the company’s Long Term Incentive Plan (LTIP) from 2020. To cover the tax liability from this vesting, Mr. McGrath sold 10,376 shares at £4.029 each and retained 11,655 shares. This transaction reflects the completion of a performance and holding period requirement, highlighting the company’s adherence to its incentive plan and potentially impacting shareholder perceptions and market confidence.

The most recent analyst rating on (GB:ZTF) stock is a Buy with a £5.40 price target. To see the full list of analyst forecasts on Zotefoams stock, see the GB:ZTF Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Zotefoams Announces CFO Succession with Nick Wright’s Appointment
Positive
Sep 22, 2025

Zotefoams has announced the appointment of Nick Wright as the new Chief Financial Officer, effective from November 1, 2025, following the retirement of Gary McGrath. This leadership change is expected to support Zotefoams’ strategic objectives and strengthen its position in the global foam technology market.

The most recent analyst rating on (GB:ZTF) stock is a Buy with a £5.40 price target. To see the full list of analyst forecasts on Zotefoams stock, see the GB:ZTF Stock Forecast page.

Regulatory Filings and Compliance
Zotefoams Directors Acquire Shares Under Incentive Plan
Neutral
Sep 12, 2025

Zotefoams plc announced that its directors and persons discharging managerial responsibilities have acquired shares under the company’s Share Incentive Plan. This move, involving the purchase of partnership shares and allocation of matching shares, underscores the company’s commitment to aligning management interests with shareholder value. The transactions were conducted in compliance with the UK Market Abuse Regulation, reflecting transparency and adherence to regulatory standards.

The most recent analyst rating on (GB:ZTF) stock is a Buy with a £5.40 price target. To see the full list of analyst forecasts on Zotefoams stock, see the GB:ZTF Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Zotefoams Unveils Global Innovation Initiatives and Leadership Appointment
Positive
Aug 28, 2025

Zotefoams has announced significant innovation initiatives, including the establishment of a Global Innovation Hub in the UK and a Footwear Innovation Centre in South Korea, alongside the appointment of Simon Comer as Chief Strategy & Innovation Officer. These initiatives, supported by a £6.8 million investment, aim to enhance Zotefoams’ innovation capabilities and competitive positioning, particularly in the rapidly growing athletic footwear market. The Global Innovation Hub will focus on developing advanced foam solutions, while the Footwear Innovation Centre will target rapid development in the Asian market, strengthening Zotefoams’ global reach and supporting its growth strategy.

The most recent analyst rating on (GB:ZTF) stock is a Buy with a £5.40 price target. To see the full list of analyst forecasts on Zotefoams stock, see the GB:ZTF Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Zotefoams Directors Acquire Shares Under Incentive Plan
Positive
Aug 12, 2025

Zotefoams plc announced that its directors and persons discharging managerial responsibilities have acquired shares under the company’s Share Incentive Plan. The transactions involved the purchase of partnership shares and the allocation of matching shares, reflecting the company’s commitment to aligning management interests with shareholder value. This move is in accordance with the UK Market Abuse Regulation and highlights Zotefoams’ strategic focus on fostering a strong internal ownership culture.

Business Operations and StrategyExecutive/Board Changes
Zotefoams Expands Asian Footprint with New Joint Venture and Leadership Appointment
Positive
Aug 5, 2025

Zotefoams has entered a joint venture with Seoheung Co. Ltd. to establish a new manufacturing facility in Vietnam, aimed at enhancing its presence in the Asian market. The collaboration de-risks Zotefoams’ investment by sharing financial and operational responsibilities, while also benefiting from Seoheung’s local manufacturing expertise. This move supports Zotefoams’ strategic transition to producing advanced 3D preforms, promising improved customer relationships and sustainability metrics. Additionally, the appointment of Brandon Thomas as Managing Director – Asia underscores the region’s importance to Zotefoams’ growth ambitions.

Business Operations and StrategyFinancial Disclosures
Zotefoams Achieves Record H1 2025 Results with Strategic Advancements
Positive
Aug 5, 2025

Zotefoams plc has reported record interim results for the first half of 2025, with a 9% increase in revenue to £77.4 million and a 37% rise in profit before tax to £11.4 million. The company has made significant strategic progress by aligning its commercial functions to focus on three global market verticals and advancing its manufacturing capabilities, including a new facility in Vietnam in partnership with Seoheung Co. Ltd. This strategic shift and operational efficiency improvements have bolstered Zotefoams’ market positioning and are expected to drive sustainable growth, despite anticipated moderation in certain sectors.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025